Polymer-Assisted Parallel Solution Phase Synthesis of Substituted Benzimidazoles

Young K. Yun; John A. Porco Jr; Jeff Labadie

doi:10.1055/s-2002-25366

LETTER

Polymer-Assisted Parallel Solution Phase Synthesis of Substituted Benzimidazoles

Young K. Yun*^a, John A. Porco Jr.^b, Jeff Labadie^a
^a Argonaut Technologies, 1101 Chess Drive, Foster City, CA 94404, USA
^b Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA
Fax: +1(650)6554300; e-Mail: yyun@argotech.com;

Abstract

Alle Artikel dieser Rubrik

Abstract

A small library of benzimidazoles was prepared using polymer-bound reagents and scavengers. Polymer-assisted reaction of diphenyl diamines with carboxylic acids yielded o-amido-diphenylamines in the presence of Polystyrene-Carbodiimide (PS-Carbodiimide) using 1-hydroxy-7-azabenzotriazole (HOAt) as additive. Excess HOAt was scavenged post-reaction using Polystyrene-Trisamine (PS-Trisamine) resin. Treatment of o-amido-diphenylamines with AcOH facilitated acid-catalyzed cyclodehydration to afford benzimidazoles in good yields and excellent purities.

Key words

combinatorial synthesis - solid-phase synthesis - polymer-supported - benzimidazole - amide coupling

Volltext

Referenzen

References

For recent reviews on parallel solution-phase synthesis using polymer reagents and scavengers, see:

<A NAME="RS07701ST-1A">1a</A> Thomson MA. Ellman JA. Chem. Rev. 1996, 96: 555

<A NAME="RS07701ST-1B">1b</A> Kaldor SW. Siegel MW. Curr. Opin. Chem. Biol. 1997, 1: 101

<A NAME="RS07701ST-1C">1c</A> Coffen DL. Tetrahedron 1998, 54: 4085

<A NAME="RS07701ST-1D">1d</A> Booth RJ. Hodges JC. J. Am. Chem. Soc. 1997, 119: 4882

<A NAME="RS07701ST-1E">1e</A> Flynn DL. Crich JZ. Devraj RV. Hockerman SL. Parlow JJ. South MS. Woodard SS. J. Am. Chem. Soc. 1997, 119: 4874

<A NAME="RS07701ST-1F">1f</A> Parlow JJ. Mischke DA. Woodard SS. J. Org. Chem. 1997, 62: 5908

<A NAME="RS07701ST-1G">1g</A> Shuker AJ. Siegel MG. Matthews DP. Wiegel LO. Tetrahedron Lett. 1997, 38: 6149

<A NAME="RS07701ST-1H">1h</A> Parlow JJ. Devraj RV. South MS. Curr. Opin. Chem. Biol. 1999, 3: 320

<A NAME="RS07701ST-1I">1i</A> Flynn DL. Med. Res. Rev. 1999, 19: 408

<A NAME="RS07701ST-1J">1j</A> Brummer O. Clapham B. Janda KD. Curr. Opion. Drug Discovery Dev. 2000, 3: 462

<A NAME="RS07701ST-1K">1k</A> Shuttleworth SJ. Allin SM. Wilson RD. Nasturica D. Synthesis 2000, 1035

<A NAME="RS07701ST-1L">1l</A> Bhalay G. Dunstan A. Glen A. Synlett 2000, 1846

<A NAME="RS07701ST-1M">1m</A> de Miguel YR. J. Chem. Soc., Perkin Trans 1 2000, 4213

<A NAME="RS07701ST-1N">1n</A> Bhattacharyya S. Comb. Chem. High Throughput Screening 2000, 3: 65

<A NAME="RS07701ST-1O">1o</A> Ley SV. Baxendale IR. Bream RN. Jackson PS. Leach AG. Longbottom DA. Nesi M. Scott JS. Storer RI. Taylor SJ. J. Chem. Soc., Perkin Trans 1 2000, 3815

<A NAME="RS07701ST-1P">1p</A> Kirschning A. Monenschein H. Wittenberg R. Angew. Chem. Int. Ed. 2001, 40: 650

Yun, Y. K.; Porco, Jr., J. A. Synthesis of Substituted Benzimidazoles using Parallel Hydrogenation, Argonaut Technologies, Application Note APN 025.

For recent publications on the solid-phase synthesis of benzimidazoles, see:

<A NAME="RS07701ST-3A">3a</A> Scarborough RM. Huang W. Tetrahedron Lett. 1999, 40: 2665

<A NAME="RS07701ST-3B">3b</A> Pan P. Sun C. Bioorg. Med. Chem. Lett. 1999, 9: 1537

<A NAME="RS07701ST-3C">3c</A> Tumelty D. Schearz M. Needels MC. Tetrahedron Lett. 1998, 39: 7467

<A NAME="RS07701ST-3D">3d</A> Mayer JP. Lewis GS. McGee C. Bankaitis-Davis D. Tetrahedron Lett. 1998, 39: 6655

<A NAME="RS07701ST-3E">3e</A> Wei GP. Phillips GB. Tetrahedron Lett. 1998, 39: 179

<A NAME="RS07701ST-3F">3f</A> Lee J. Gauthier D. Rivero RA. Tetrahedron Lett. 1998, 39: 201

<A NAME="RS07701ST-3G">3g</A> Phillips GB. Wei GP. Tetrahedron Lett. 1996, 37: 4887

<A NAME="RS07701ST-4A">4a</A> White AW. Almassy R. Calvert AH. Curtin NJ. Griffin RJ. Hostomsky Z. Maegley K. Newell DR. Srinivasan S. Golding BT. J. Med. Chem. 2000, 43: 4084

<A NAME="RS07701ST-4B">4b</A> Chua M. Shi D. Wrigley S. Bradshaw TD. Hutchinson I. Shaw PN. Barrett D. Stanley LA. Stevens MFG. J. Med. Chem. 1999, 42: 381

<A NAME="RS07701ST-4C">4c</A> Palmer B. Smaill J. Boyd M. Boschelli D. J. Med. Chem. 1998, 41: 5457

<A NAME="RS07701ST-4D">4d</A> Orjales A. Mosquera R. Labeaga L. Rodes R. J. Med. Chem. 1997, 40: 586

<A NAME="RS07701ST-4E">4e</A> Terauchi H. Tanitame A. Nakamura K. Seto Y. Nishikawa Y. J. Med. Chem. 1997, 40: 313

<A NAME="RS07701ST-4F">4f</A> Zarrinmayeh H. Zimmerman DM. Cantrell BE. Schober DA. Bruns RF. Gackenheimer SL. Ornstein PL. Hipskind PA. Britton TC. Gehlert DR. Bioorg. Med. Chem. Lett. 1999, 9: 647

<A NAME="RS07701ST-5A">5a</A> Zhang L. Wats WM. Costello TD. Ma P. Ensinger CL. Rodgers JM. Jacobson IC. Rajagopalan P. Tetrahedron Lett. 1995, 36: 8387

<A NAME="RS07701ST-5B">5b</A> Lee J. Murray WV. Rivero RA. J. Org. Chem. 1997, 62: 3874

<A NAME="RS07701ST-5C">5c</A> Mazurov A. Tetrahedron Lett. 2000, 41: 7

<A NAME="RS07701ST-5D">5d</A> Arumugam V. Routledge A. Abell C. Balasubramanian S. Tetrahedron Lett. 1997, 38: 6473

<A NAME="RS07701ST-5E">5e</A> Kiselyov A. Armstrong RW. Tetrahedron Lett. 1997, 38: 6163

<A NAME="RS07701ST-5F">5f</A> Rylander P. Hydrogenation Methods Academic Press; San Diego CA: 1985. p.104-116

<A NAME="RS07701ST-6A">6a</A> Veale CA. Steelman GB. Chow MM. J. Org. Chem. 1993, 58: 4490

<A NAME="RS07701ST-6B">6b</A> Batti R. Gouverneur V. Mioskowski C. Synthesis 1999, 927

<A NAME="RS07701ST-7A">7a</A> Eynde JJV. Delfosse F. Lor P. Haverbeke YV. Tetrahedron 1995, 51: 5813

<A NAME="RS07701ST-7B">7b</A> Thomas JB. Fall MJ. Cooper JB. Burgess JP. Carroll FI. Tetrahedron Lett. 1997, 38: 5099

<A NAME="RS07701ST-7C">7c</A> Moore AG. Schow SR. Lum RT. Nelson MG. Melville CR. Synthesis 1999, 1123

Representative procedure for amide coupling using PS-carbodiimide and PS-Trisamine:

Method A: PS-Carbodiimide resin (2.0 equiv) was added to a dry reaction vessel. The acid (1.5 equiv) in CH₂Cl₂ (with 10% DMF added if required) was added to the dry resin and the mixture stirred at room temperature. After 5 min., amine (1.0 equiv) in CH₂Cl₂ was added and the reaction stirred at room temperature for 12 h to afford the amide product. Typical reaction solvent volumes are 10 mL/g resin.

Method B: Amine (1.0 equiv) and acid (1.5 equiv) in CH₂Cl₂ (with 10% DMF added if necessary) were added to a dry reaction vessel and the mixture stirred for 10 min prior to addition of PS-Carbodiimide resin (2 equiv) with a reaction solvent volume of 10 mL/g resin. The reaction was then stirred overnight.

Method C: PS-Carbodiimide (2.0 equiv), acid (1.5 equiv) and HOAt (1.7 equiv) were dissolved in CH₂Cl₂ and added to a dry reaction vessel and stirred for 5-10 min prior to addition of amine (1.0 equiv). The reaction was stirred at room temperature overnight. After the reaction, the HOAt was scavenged using PS-Trisamine resin (5 equiv) for 2 hours at room temperature prior to filtration.

General Procedure for Reaction Work-up: The reaction mixture was filtered and the amide product was collected in the filtrate. The resin was further washed an additional two times with the reaction solvent (CH₂Cl₂ or CH₂Cl₂-DMF as needed for solubility). A sample from the combined fractions was generally analyzed by GC before concentration to evaluate product purity and presence (if any) of unreacted amine. Concentration afforded the amide product.

<A NAME="RS07701ST-9A">9a</A> Weidner JJ. Parlow JJ. Flynn DL. Tetrahedron Lett. 1999, 40: 239

<A NAME="RS07701ST-9B">9b</A> Nicewonger RB. Ditto L. Varady L. Tetrahedron Lett. 2000, 41: 2323

<A NAME="RS07701ST-10A">10a</A> Nestor JJ. Horner BL. Ho TL. Jones GH. McRae GI. Vickery BH. J. Med. Chem. 1984, 27: 320

<A NAME="RS07701ST-10B">10b</A> Ogatta M. Yoshimura T. Fijji H. Ito Y. Katsuki T. Synlett 1993, 728

<A NAME="RS07701ST-10C">10c</A> Clarborne CF. Liverton NJ. Tetrahedron Lett. 1998, 39: 8939

Representative spectroscopic data for compounds 2-4, 6, and 7.2d: ¹H NMR (CDCl₃, 300 MHz): δ 9.96 (bs, 1 H, NH), 8.50 (dd, J = 8.1 Hz, 1.5 Hz, 1 H, CH), 8.43 (dd, J = 4.8 Hz, 1.8 Hz, 1 H, CH), 7.48 (d, J = 9.3 Hz, 2 H, CH), 6.93 (d, J = 9.0 Hz, 2 H, CH), 6.77 (dd, J = 8.7 Hz, 4.8 Hz, 1 H, CH), 3.82 (s, 3 H, CH₃); ¹³C NMR (CDCl₃, 75 MHz): δ 157.12, 155.45, 150.81, 135.46, 130.61, 128.30, 124.78, 114.26, 113.34, 55.48 ppm.
3d: ¹H NMR (d₆-DMSO, 300 MHz): δ 7.95 (bs, 1 H, NH), 7.49 (d, J = 9.0 Hz, 2 H, CH), 7.36 (dd, J = 4.8 Hz, 1.2 Hz, 1 H, CH), 6.90 (dd, J = 7.5 Hz, 1.2 Hz, 1 H, CH), 6.86 (d, J = 9.0 Hz, 1 H, CH), 6.58 (dd, J = 7.8 Hz, 5.4 Hz, 1 H, CH), 5.60 (bs, 2 H, NH₂), 3.71 (s, 3 H, CH₃); ¹³C NMR (d₆-DMSO, 75 MHz): δ 154.46, 144.13, 134.11, 132.20, 131.94, 121.61, 119.56, 114.89, 114.11, 55.34 ppm.
4d: ¹H NMR (CDCl₃, 300 MHz): δ 8.44 (d, J = 4.8 Hz, 1 H, CH), 8.25 (s, 1 H, CH), 8.13 (d, J = 7.8 Hz, 1 H, CH), 7.60 (d, J = 8.7 Hz, 2 H, CH), 7.30 (dd, J = 8.1 Hz, 4.8 Hz, 1 H, CH), 7.08 (d, 2 H, CH), 3.85 (s, 3 H, CH₃); ¹³C NMR (CDCl₃, 75 MHz): δ 159.30, 147.12, 144.90, 143.29, 135.71, 128.23, 128.01, 125.37, 118.71, 115.01, 55.61 ppm.
6i: ¹H NMR (CDCl₃, 300 MHz): δ 9.17 (s, 1 H, CH), 7.98 (d, J = 8.4 Hz, 2H, CH), 7.71 (dd, J = 8.7, 2.1 Hz, 2 H, CH), 7.55 (s, 1 H, CH), 7.43 (d, J = 8.7 Hz, 1 H, CH), 6.86 (d, J = 8.7 Hz, 1 H, CH), 5.41 (s, 1 H, CH), 3.23 (t, J = 6.9 Hz, 2 H, CH₂), 1.61 (tt, J = 7.5, 7.5 Hz, 2 H, CH₂), 1.43 (tq, J = 8.1, 7.2 Hz, 2 H, CH₂), 0.91 (t, J = 7.5 Hz, 3 H, CH₃) ppm.
7i: ¹H NMR (CDCl₃, 300 MHz): δ 7.97 (s, 1 H, CH), 7.82 (d, J = 8.4 Hz, 1 H, CH), 7.72 (d, J = 8.4 Hz, 2 H, CH), 7.67 (d, J = 8.7 Hz, 2 H, CH), 7.54 (d, J = 8.1 Hz, 1 H, CH), 4.27 (t, J = 7.2 Hz, 2 H, CH₂), 1.55 (tt, J = 7.5, 7.5 Hz, 2 H, CH₂), 1.05 (tq, J = 7.8, 7.2 Hz, 2 H, CH₂), 0.66 (t, J = 7.5 Hz, 3 H, CH₃); ¹³C NMR (CDCl₃, 75 MHz): δ 154.27, 141.92, 137.99, 131.89, 131.22, 129.13, 123.83, 119.17, 116.62, 44.18, 31.14, 19.14, 13.23 ppm.

Yun, Y. K.; Vo, L.; Porco, Jr., J. A.; Labadie, J. 219^th ACS National Meeting, 2000, ORGN 1.